// App-Quantinova.ai

PB1694 : REAL WORLD TWO-CENTER EXPERIENCE OF DARATUMUMAB MONOTHERAPY IN HEAVILY PRETREATED RELAPSED/ REFRACTORY MULTIPLE MYELOMA

Researchers

Presenter

  • Irene Sanchez

Principal Investigators

  • Ho Pui Jeff Lam

  • Grace Milner

  • Inas El-Najjar

  • Sajitha Sachchithanantham

  • Mary Gleeson

  • Majid Kazmi

  • Katharine Bailey

  • Reuben Benjamin

  • Kirsty Cuthill

  • Lisa Yuen

  • Julio Garcia

  • Matthew Streetly

Medical Centers

  • Hematology,Hospital Universitario Príncipe de Asturias,Alcalá de Henares, Madrid,Spain

  • Haematological Medicine, Kings College Hospital, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • daratumumab Intravenous

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved